Selleckchem Inc

View website

Bio Active Compounds.

Recent products

Ustekinumab (anti-IL-12/IL-23)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Obinutuzumab (anti-CD20)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Cemiplimab (anti-PD-1)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Tremelimumab (anti-CTLA-4)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Denosumab (anti-RANK ligand)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Infliximab (anti-TNF-alpha)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Panitumumab (anti-EGFR)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Spartalizumab (anti-PD-1)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Camrelizumab (anti-PD-1)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Avelumab (anti-PD-L1)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Durvalumab (anti-PD-L1)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Tocilizumab (anti-IL-6R)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Sarilumab (anti-IL-6R?)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Adalimumab (anti-TNF-alpha)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Rituximab (anti-CD20)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order

Pertuzumab (anti-HER2)

£243.00 – £2,432.00 / €340.20 – €3,404.80 Standard

View and order
1 … 703 704 705